Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 5891F

GlaxoSmithKline PLC

28 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Sir Andrew Witty

Position/status

CEO

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Sale of Ordinary Shares on 27 July 2016 at a price of £16.9350.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.9350	10,000

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-27

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The exercise of options over 26,800 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£14.88

26,800

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-27

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The sale of 26,800 Ordinary Shares following the exercise of options granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£16.942

26,800

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-27

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The exercise of options over 24,186 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£11.47

24,186

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-27

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The sale of 24,186 Ordinary Shares following the exercise of options granted on granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£16.938

24,186

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-27

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The exercise of options over 2,614 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£11.47

2,614

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The sale of 2,614 Ordinary Shares following the exercise of options granted on granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)

Volume(s)

£17.035

2,614

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

Senior Vice President, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Sale of Ordinary Shares on 28 July 2016 at a price of £16.9757.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.9757	43,000

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDVLFLQDFFBBK

RNS metadata

Title: Director/PDMR Shareholding
Time: 19:22:17
Date: 28 Jul 2016
Category: Director/PDMR dealings
ID: 5891F